Bolt Biotherapeutics's latest marketcap:
As of 06/12/2025, Bolt Biotherapeutics's market capitalization has reached $12.52 M. According to our data, Bolt Biotherapeutics is the 38855th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 12.52 M |
| Revenue (ttm) | 3.64 M |
| Net Income (ttm) | -63,347,000 |
| Shares Out | 1.92 M |
| EPS (ttm) | -33.12 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/12/2025 |
Bolt Biotherapeutics's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/12/2025 | $12.52 M | -37.83% | 38855 |
| 12/31/2024 | $20.48 M | -51.84% | 34007 |
| 12/29/2023 | $42.52 M | -13.15% | 28875 |
| 12/30/2022 | $48.96 M | -73.2% | 27005 |
| 12/31/2021 | $182.69 M | 19357 |
Company Profile
About Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer treatment.
Key Product Candidates
- BDC-1001: Currently in clinical development for HER2-positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancers.
- BDC-3042: An agonist antibody targeting Dectin-2, designed for a range of tumors such as head and neck, non-small cell lung, ovarian, and triple-negative breast cancers.
Strategic Collaborations
The company has established partnerships with leading organizations, including:
- Toray Industries
- Genmab A/S
- Innovent Biologics, Inc.
- Bristol-Myers Squibb
- F. Hoffmann-La Roche Ltd
Additionally, Bolt Biotherapeutics holds a license agreement with Stanford University.
Company Background
Originally named Bolt Therapeutics, Inc., the company rebranded as Bolt Biotherapeutics, Inc. in July 2015. Founded the same year, it is headquartered in Redwood City, California.
Frequently Asked Questions
-
What is Bolt Biotherapeutics's (BOLT) current market cap?As of 06/12/2025, Bolt Biotherapeutics (including the parent company, if applicable) has an estimated market capitalization of $12.52 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Bolt Biotherapeutics (BOLT) rank globally by market cap?Bolt Biotherapeutics global market capitalization ranking is approximately 38855 as of 06/12/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.